United Services Automobile Association United Therapeutics Corp Transaction History

United Services Automobile Association

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 13, 2019	SELL	$74.85 - $85.99 $3.82 Million - $4.39 Million	-51,077 Closed	0 $0
Q2 2019 Aug 16, 2019	SELL	$76.06 - $120.81 $2.27 Million - $3.6 Million	-29,808 Reduced 36.85%	51,077 $3.99 Million
Q1 2019 May 13, 2019	BUY	$107.15 - $126.84 $523,642 - $619,867	4,887 Added 6.43%	80,885 $9.49 Million
Q4 2018 Feb 13, 2019	BUY	$101.4 - $128.73 $1.43 Million - $1.82 Million	14,145 Added 22.87%	75,998 $8.28 Million
Q3 2018 Nov 13, 2018	BUY	$113.81 - $129.46 $523,981 - $596,033	4,604 Added 8.04%	61,853 $7.91 Million
Q2 2018 Sep 27, 2018	SELL	$101.14 - $118.31 $7.14 Million - $8.35 Million	-70,573 Reduced 55.21%	57,249 $6.48 Million
Q2 2018 Aug 10, 2018	BUY	$101.14 - $118.31 $6.26 Million - $7.32 Million	61,908 Added 93.92%	127,822 $4.1 Million
Q1 2018 May 14, 2018	BUY	$107.21 - $151.94 $2.61 Million - $3.71 Million	24,387 Added 58.73%	65,914 $7.41 Million
Q4 2017 Feb 14, 2018	BUY	$118.58 - $151.28 $663,810 - $846,865	5,598 Added 15.58%	41,527 $6.14 Million
Q3 2017 Nov 14, 2017	BUY	$114.6 - $136.81 $4.12 Million - $4.92 Million	35,929	35,929 $4.21 Million

669

42.8M

194K

295K

Ticker UTHR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,516,300
Market Cap $16.7B
Description
United Therapeutics Corporation, a biotechnology company, engages in the development and commercialization of products to address the unmet medical needs of patients with chronic and life-threatening diseases in the United States and internationally. Its commercial therapies include Remodulin to treat patients with pulmonary arterial hypertensio...

Get notified when there are updates to the investment portfolio of United Services Automobile Association, based on Form 13F filings with the SEC.

Stay updated on United Services Automobile Association with notifications on news.